Evidence map›Paper›PMID 33168513›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Small interfering RNA-mediated programmed cell death-ligand 1 silencing in human glioma cells enhances human CD8

Zhen Wang, Wen Huang, Bohong Cen, Yuanyi Wei, Lumin Liao, Guoxian Li, Aimin Ji

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhen WangDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Wen HuangDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Bohong CenDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Yuanyi WeiDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Lumin LiaoDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Guoxian LiDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Aimin JiDepartment of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of small interfering RNA (siRNA)-mediated silencing of programmed cell deathligand 1 (PD-L1) in human glioma cells on the cytotoxicity of human CD8

methodsA siRNA sequence targeting PD-L1 gene was designed and transfected into human glioma U87 MG cells via lipofectamine 2000, and the gene silencing effect was validated using RT-qPCR, Western blotting, and flow cytometry. The transfected cells were co-cultured with human CD8

resultsThe siRNA sequence showed strong PD-L1 gene-silencing effect at both mRNA and protein levels in U87 MG cells. Compared with the control cells, the transfected U87 MG cells showed significantly increased vulnerability to the cytotoxicity of human CD8

conclusionsTransfection of human glioma U87 MG cells with the specific siRNA targeting PD-L1 obviously enhances the toxicity of human T lymphocytes in the co-culture.

Indexed as

CD8+ T lymphocytesgliomasprogrammed cell death-ligand 1small interfering RNA

Identifiers

PMID33168513
PMCPMC6765535
OpenAlexW2890266825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.